Bevacizumab combined with lowdose S-1 as maintenance therapy with a long progression-free survival in an elderly patient with heavily pre-treated advanced gastric cancer: A case report

Author： Fang   Wang   Xu  

Publisher： Spandidos Publications

ISSN： 2049-9442

Source： Biomedical Reports, Vol.1, Iss.2, 2013-01, pp. : 239-242

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Knockdown of PD-L1 in Human Gastric Cancer Cells Inhibits Tumor Progression and Improves the Cytotoxic Sensitivity to CIK Therapy

By  

Cellular Physiology and Biochemistry, Vol. 41, Iss. 3, 2017-02 ,pp. : 907-920

Karger

Access to resources Recommend Favorite

Factors Associated with Post-Progression Survival in Patients with Advanced Hepatocellular Carcinoma Treated with Sorafenib

By Otsuka Taiga   Nakashita Shunya   Yanagita Kimihiko   Ario Keisuke   Kawasoe Hiroaki   Kawazoe Seiji   Eguchi Yuichiro   Mizuta Toshihiko   Chan Stephen L.  

Diseases, Vol. 3, Iss. 2, 2015-05 ,pp. : 68-77

MDPI

Access to resources Recommend Favorite

Modulation of extracellular signal‐related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol‐pretreated astrocyte cultures treated with competence and progression growth factors

By  

JOURNAL OF NEUROSCIENCE RESEARCH, Vol. 93, Iss. 9, 2015-09 ,pp. : 1378-1387

John Wiley & Sons Inc

Access to resources Recommend Favorite

XIST promotes gastric cancer (GC) progression through TGF‐β1 via targeting miR‐185

By  

JOURNAL OF CELLULAR BIOCHEMISTRY, Vol. 119, Iss. 3, 2018-03 ,pp. : 2787-2796

John Wiley & Sons Inc

Access to resources Recommend Favorite

CD44 and CD44v6 are Correlated with Gastric Cancer Progression and Poor Patient Prognosis: Evidence from 42 Studies

By  

Cellular Physiology and Biochemistry, Vol. 40, Iss. 3-4, 2016-11 ,pp. : 567-578

Karger

Access to resources Recommend Favorite